Wednesday, March 6, 2019
Renowned Jamaican Scientist Dr. Manley West
Renowned Jamaican scientist Dr. Manley West Dr West was a scientist. He taught pharmaco-logy at the University of the West Indies, Mona. Significantly, with Dr Albert Lockhart, he developed Canasol, a drug for the intervention of the eye disease, glaucoma, from cannabis, or ganja. Born in Portland, West attended the Titchfield risque School. He graduated from the University of London, England, in 1967 with a Doctor of Philosophy in pharmacological medicine.His career at the UWI began as assistant lecturer in pharmacology in 1964, from which position he was promoted to lecturer and internal examiner in pharmacology in 1968. Thereafter, in 1975, West served as acting guide on of the Department of Pharmacology and in that same year was appointed whirl of the Department of Pharmacology and chief internal examiner. He was appointed prof of pharmacology in 1981.West has received theme and international acclaim for his phylogenesis of the drug Canasol, as a treatment for glaucoma, for which achievement he was awarded the club of Merit from the political science. In 1985, Professor West along with Dr. Albert Lockhart received national and international acclaim, for their development of Canasol. Both were awarded the Order of Merit from the Jamaican Government in 1987. Professor West was also awarded the Gold Musgrave medal from the demonstrate of Jamaica for his pioneering work with the drug.In 2001, ProfessorWest, and Dr. Lockhart introduced a cannabis-derived medication called Cantimol to treat the potentially debilitate condition of glaucoma. It was the worlds first combination of an alpha agonist and a matter blocker (two types of drugs) in one bottle for the treatment of this disease. The Food and horticulture Organization (FAO) also conferred on him the Bio-Diversity Gold medal for the conversion ofa plant compound to medicine, and he was awarded the Legacy ofHonor, for the Caribbean for his contribution to mankind.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment